Development asset linked to Esteve Pharmaceuticals in public FDA and regional records.
pharma · Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome)
Esteve Pharmaceuticals
Esteve Pharmaceuticals drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Barcelona, ES HQ
46 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Barcelona, ES
- Employees
- 46
- Programs
- 1
- Drugs
- 3
- Patents
- 0
Esteve Pharmaceuticals pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Esteve Pharmaceuticals drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Esteve Pharmaceuticals in public FDA and regional records.
-
US regulatory status: approved.